EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSSDUG00000013729
Gene Symbol: RARG
3 Cross references
353 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSSDUG00000005479
Gene Symbol: LOC111221558
3 Cross references
377 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSSDUG00000020066
Gene Symbol: RXRA
3 Cross references
225 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSSDUG00000000886
Gene Symbol: LOC111239446
3 Cross references
224 Possible Orthologues:

Ribosomal Protein L10 Like

Ensembl ID : ENSSDUG00000010413
Gene Symbol: RPL10L
3 Cross references
8 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSSDUG00000010399
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSSDUG00000008255
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSSDUG00000020052
Gene Symbol: RPL12
3 Cross references
477 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSSDUG00000001262
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSSDUG00000017181
Gene Symbol: RPL13A
3 Cross references
368 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSSDUG00000001309
Gene Symbol: RPL14
3 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSSDUG00000011517
Gene Symbol: RPL15
3 Cross references
357 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).